IL23A and ovarian carcinoma: Then tumor specimens undergoing advanced ovarian cancer treatment were extracted and real-time PCR was performed to test IL-23p19 expression, and simultaneously, H&E staining was carried out to determine degrees of differentiation of the tissues.